Standard InChI: InChI=1S/C19H25ClN2O2/c1-19(2)10-11-6-12(20)7-16(17(11)24-19)18(23)21-13-8-14-4-5-15(9-13)22(14)3/h6-7,13-15H,4-5,8-10H2,1-3H3,(H,21,23)/t13-,14+,15-
1.Schaus JM, Thompson DC, Bloomquist WE, Susemichel AD, Calligaro DO, Cohen ML.. (1998) Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives., 41 (11):[PMID:9599243][10.1021/jm970857f]
2.Robertson DW, Lacefield WB, Bloomquist W, Pfeifer W, Simon RL, Cohen ML.. (1992) Zatosetron, a potent, selective, and long-acting 5HT3 receptor antagonist: synthesis and structure-activity relationships., 35 (2):[PMID:1732548][10.1021/jm00080a016]
3.Robertson DW, Lacefield WB, Bloomquist W, Pfeifer W, Simon RL, Cohen ML.. (1992) Zatosetron, a potent, selective, and long-acting 5HT3 receptor antagonist: synthesis and structure-activity relationships., 35 (2):[PMID:1732548][10.1021/jm00080a016]
4.Molnar L, Keseru GM.. (2002) A neural network based virtual screening of cytochrome P450 3A4 inhibitors., 12 (3):[PMID:11814811][10.1016/s0960-894x(01)00771-5]
5.Wang YH, Li Y, Li YH, Yang SL, Yang L.. (2005) Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism., 15 (18):[PMID:15990295][10.1016/j.bmcl.2005.06.015]
6.Maksay G, Nemes P, Bíró T.. (2004) Synthesis of tropeines and allosteric modulation of ionotropic glycine receptors., 47 (25):[PMID:15566307][10.1021/jm040814g]